52 related articles for article (PubMed ID: 3026637)
1. Retrovirus antigens recognized by cytolytic T lymphocytes activate tumor rejection in vivo.
Plata F; Langlade-Demoyen P; Abastado JP; Berbar T; Kourilsky P
Cell; 1987 Jan; 48(2):231-40. PubMed ID: 3026637
[TBL] [Abstract][Full Text] [Related]
2. Immunocyte Membrane-Coated Nanoparticles for Cancer Immunotherapy.
Gong P; Wang Y; Zhang P; Yang Z; Deng W; Sun Z; Yang M; Li X; Ma G; Deng G; Dong S; Cai L; Jiang W
Cancers (Basel); 2020 Dec; 13(1):. PubMed ID: 33396603
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and protective efficacy of recombinant human T-cell leukemia/lymphoma virus type 1 NYVAC and naked DNA vaccine candidates in squirrel monkeys (Saimiri sciureus).
Kazanji M; Tartaglia J; Franchini G; de Thoisy B; Talarmin A; Contamin H; Gessain A; de Thé G
J Virol; 2001 Jul; 75(13):5939-48. PubMed ID: 11390595
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic T cell response against the chimeric p210 BCR-ABL protein in patients with chronic myelogenous leukemia.
Yotnda P; Firat H; Garcia-Pons F; Garcia Z; Gourru G; Vernant JP; Lemonnier FA; Leblond V; Langlade-Demoyen P
J Clin Invest; 1998 May; 101(10):2290-6. PubMed ID: 9593785
[TBL] [Abstract][Full Text] [Related]
5. Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors.
Ossendorp F; Mengedé E; Camps M; Filius R; Melief CJ
J Exp Med; 1998 Mar; 187(5):693-702. PubMed ID: 9480979
[TBL] [Abstract][Full Text] [Related]
6. Use of recombinant protein to identify a motif-negative human cytotoxic T-cell epitope presented by HLA-A2 in the hepatitis C virus NS3 region.
Kurokohchi K; Akatsuka T; Pendleton CD; Takamizawa A; Nishioka M; Battegay M; Feinstone SM; Berzofsky JA
J Virol; 1996 Jan; 70(1):232-40. PubMed ID: 8523531
[TBL] [Abstract][Full Text] [Related]
7. Characterization of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte clones isolated during acute seroconversion: recognition of autologous virus sequences within a conserved immunodominant epitope.
Safrit JT; Andrews CA; Zhu T; Ho DD; Koup RA
J Exp Med; 1994 Feb; 179(2):463-72. PubMed ID: 8294860
[TBL] [Abstract][Full Text] [Related]
8. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.
Koup RA; Safrit JT; Cao Y; Andrews CA; McLeod G; Borkowsky W; Farthing C; Ho DD
J Virol; 1994 Jul; 68(7):4650-5. PubMed ID: 8207839
[TBL] [Abstract][Full Text] [Related]
9. Multiplicity of virus-encoded helper T-cell epitopes expressed on FBL-3 tumor cells.
Iwashiro M; Kondo T; Shimizu T; Yamagishi H; Takahashi K; Matsubayashi Y; Masuda T; Otaka A; Fujii N; Ishimoto A
J Virol; 1993 Aug; 67(8):4533-42. PubMed ID: 7687300
[TBL] [Abstract][Full Text] [Related]
10. Cell-invasive activity of epitope-tagged adenylate cyclase of Bordetella pertussis allows in vitro presentation of a foreign epitope to CD8+ cytotoxic T cells.
Sebo P; Fayolle C; d'Andria O; Ladant D; Leclerc C; Ullmann A
Infect Immun; 1995 Oct; 63(10):3851-7. PubMed ID: 7558291
[TBL] [Abstract][Full Text] [Related]
11. Retroviral properties inherent to viral erythrocytic infection in sea bass.
Pintó RM; Ribes E; Jofre J; Bosch A
Arch Virol; 1995; 140(4):721-35. PubMed ID: 7540830
[TBL] [Abstract][Full Text] [Related]
12. An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans.
Shirai M; Okada H; Nishioka M; Akatsuka T; Wychowski C; Houghten R; Pendleton CD; Feinstone SM; Berzofsky JA
J Virol; 1994 May; 68(5):3334-42. PubMed ID: 7512163
[TBL] [Abstract][Full Text] [Related]
13. Immunogenic determinants of a neuropathogenic murine leukemia virus.
Robbins DS; Remington MP; Sarzotti M; St Louis D; Hoffman PM
J Virol; 1995 Nov; 69(11):6847-51. PubMed ID: 7474098
[TBL] [Abstract][Full Text] [Related]
14. Xenogenization of tumor cells by transfection with plasmid containing env gene of Friend leukemia virus.
Sugiura C; Itaya T; Kondoh N; Oikawa T; Kuzumaki N; Takeichi N; Hosokawa M; Kobayashi H
Jpn J Cancer Res; 1988 Dec; 79(12):1259-63. PubMed ID: 3148594
[TBL] [Abstract][Full Text] [Related]
15. 5' long terminal repeats of myc-associated proviruses appear structurally intact but are functionally impaired in tumors induced by avian leukosis viruses.
Goodenow MM; Hayward WS
J Virol; 1987 Aug; 61(8):2489-98. PubMed ID: 3037111
[TBL] [Abstract][Full Text] [Related]
16. FBL-reactive CD8+ cytotoxic and CD4+ helper T lymphocytes recognize distinct Friend murine leukemia virus-encoded antigens.
Klarnet JP; Kern DE; Okuno K; Holt C; Lilly F; Greenberg PD
J Exp Med; 1989 Feb; 169(2):457-67. PubMed ID: 2562982
[TBL] [Abstract][Full Text] [Related]
17. Primary virus-induced lymphomas evade T cell immunity by failure to express viral antigens.
Vasmel WL; Sijts EJ; Leupers CJ; Matthews EA; Melief CJ
J Exp Med; 1989 Apr; 169(4):1233-54. PubMed ID: 2538550
[TBL] [Abstract][Full Text] [Related]
18. Human immunodeficiency virus-specific cytotoxic responses of seropositive individuals: distinct types of effector cells mediate killing of targets expressing gag and env proteins.
Riviere Y; Tanneau-Salvadori F; Regnault A; Lopez O; Sansonetti P; Guy B; Kieny MP; Fournel JJ; Montagnier L
J Virol; 1989 May; 63(5):2270-7. PubMed ID: 2522999
[TBL] [Abstract][Full Text] [Related]
19. The tumor rejection antigen separated from Rous sarcoma virus-induced murine fibrosarcoma exhibits a molecular weight of approximately 60 kD but differs from functional pp60src.
Suda T; Shimizu J; Muramatsu M; Kimura K; Yoshida TO; Fukami Y; Fujiwara H; Hamaoka T
Jpn J Cancer Res; 1989 Sep; 80(9):879-86. PubMed ID: 2480944
[TBL] [Abstract][Full Text] [Related]
20. Separation of the tumor rejection antigen of Rous sarcoma virus-induced murine fibrosarcoma.
Suda T; Shimizu J; Mizushima Y; Fujiwara H; Hamaoka T
Jpn J Cancer Res; 1988 Mar; 79(3):365-74. PubMed ID: 2453498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
